Cite
HARVARD Citation
Mariottini, A. et al. (2019). Safety and efficacy of autologous hematopoietic stem‐cell transplantation following natalizumab discontinuation in aggressive multiple sclerosis. European journal of neurology. pp. 624-630. [Online].